MERCK & CO. INC. (1MRKX.MI) Stock Price & Overview

BIT:1MRKX • US58933Y1055

Current stock price

99.5 EUR
-2.5 (-2.45%)
Last:

The current stock price of 1MRKX.MI is 99.5 EUR. Today 1MRKX.MI is down by -2.45%. In the past month the price increased by 30.58%.

1MRKX.MI Key Statistics

1-Month Range71.5 - 110.2
Current 1MRKX.MI stock price positioned within its 1-month range.
Market Cap
246.003B
P/E
12.48
Fwd P/E
22.16
EPS (TTM)
7.97
Dividend Yield
2.84%

1MRKX.MI Stock Performance

Today
-2.45%
1 Week
+10.07%
1 Month
+30.58%
3 Months
+39.36%
Longer-term
6 Months -19.11%
1 Year N/A
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

1MRKX.MI Stock Chart

MERCK & CO. INC. / 1MRKX Daily stock chart

1MRKX.MI Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to 1MRKX.MI.


Chartmill TA Rating
Chartmill Setup Rating

1MRKX.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to 1MRKX.MI. 1MRKX.MI has an excellent profitability rating, but there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

1MRKX.MI Earnings

On February 3, 2026 1MRKX.MI reported an EPS of 2.09 and a revenue of 16.40B. The company beat EPS expectations (2.98% surprise) and beat revenue expectations (0.31% surprise).

Next Earnings DateApr 30, 2026
Last Earnings DateFeb 3, 2026
PeriodQ4 / 2025
EPS Reported$2.09
Revenue Reported16.4B
EPS Surprise 2.98%
Revenue Surprise 0.31%

1MRKX.MI Forecast & Estimates

35 analysts have analysed 1MRKX.MI and the average price target is 108.2 EUR. This implies a price increase of 8.74% is expected in the next year compared to the current price of 99.5.

For the next year, analysts expect an EPS growth of -43.62% and a revenue growth 3.06% for 1MRKX.MI


Analysts
Analysts78.29
Price Target108.2 (8.74%)
EPS Next Y-43.62%
Revenue Next Year3.06%

1MRKX.MI Groups

Sector & Classification

Sub-Industry
Pharmaceuticals
Index Membership

1MRKX.MI Financial Highlights

Over the last trailing twelve months 1MRKX.MI reported a non-GAAP Earnings per Share(EPS) of 7.97. The EPS increased by 20.16% compared to the year before.


Income Statements
Revenue(TTM)65.01B
Net Income(TTM)18.25B
Industry RankSector Rank
PM (TTM) 28.08%
ROA 13.34%
ROE 34.7%
Debt/Equity 0.89
Chartmill High Growth Momentum
EPS Q2Q%21.51%
Sales Q2Q%4.97%
EPS 1Y (TTM)20.16%
Revenue 1Y (TTM)1.31%

1MRKX.MI Ownership

Ownership
Inst Owners81.17%
Shares2.47B
Float2.47B
Ins Owners0.05%
Short Float %N/A
Short RatioN/A

About 1MRKX.MI

Company Profile

1MRKX logo image Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey and currently employs 75,000 full-time employees. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The firm sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The company sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.

Company Info

IPO: 1941-01-01

MERCK & CO. INC.

126 East Lincoln Avenue, P.O. Box 2000

Rahway NEW JERSEY US

Employees: 75000

1MRKX Company Website

1MRKX Investor Relations

Phone: 19087404000

MERCK & CO. INC. / 1MRKX.MI FAQ

What does MERCK & CO. INC. do?

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey and currently employs 75,000 full-time employees. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The firm sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The company sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.


Can you provide the latest stock price for MERCK & CO. INC.?

The current stock price of 1MRKX.MI is 99.5 EUR. The price decreased by -2.45% in the last trading session.


Does MERCK & CO. INC. pay dividends?

MERCK & CO. INC. (1MRKX.MI) has a dividend yield of 2.84%. The yearly dividend amount is currently 2.84.


What is the ChartMill technical and fundamental rating of 1MRKX stock?

1MRKX.MI has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


On which exchange is 1MRKX.MI stock listed?

1MRKX.MI stock is listed on the Euronext Milan exchange.


Would investing in MERCK & CO. INC. be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 1MRKX.MI.


What is MERCK & CO. INC. worth?

MERCK & CO. INC. (1MRKX.MI) has a market capitalization of 246.00B EUR. This makes 1MRKX.MI a Mega Cap stock.